UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

New insights into the molecular mechanisms of the fibrinolytic system

Journal of thrombosis and haemostasis, 2009-01, Vol.7 (1), p.4-13

2009

Volltextzugriff (PDF)

The Hypercoagulable State in Cushing's Disease Is Associated with Increased Levels of Procoagulant Factors and Impaired Fibrinolysis, But Is Not Reversible after Short-Term Biochemical Remission Induced by Medical Therapy

The journal of clinical endocrinology and metabolism, 2012-04, Vol.97 (4), p.1303-1310

2012

Volltextzugriff (PDF)

An international study on the feasibility of a standardized combined plasma clot turbidity and lysis assay: communication from the SSC of the ISTH

Journal of thrombosis and haemostasis, 2018-05, Vol.16 (5), p.1007-1012

2018

Volltextzugriff (PDF)

Oxidized high‐density lipoprotein reduces blood clot firmness

Journal of thrombosis and haemostasis, 2013-03, Vol.11 (3), p.561-563

2013

Volltextzugriff (PDF)

The B domain of coagulation factor VIII interacts with the asialoglycoprotein receptor

Journal of thrombosis and haemostasis, 2005-06, Vol.3 (6), p.1257-1265

2005

Volltextzugriff (PDF)

Compaction of fibrin clots reveals the antifibrinolytic effect of factor XIII

Journal of thrombosis and haemostasis, 2016-07, Vol.14 (7), p.1453-1461

2016

Volltextzugriff (PDF)

High functional levels of thrombin‐activatable fibrinolysis inhibitor are associated with an increased risk of first ischemic stroke

Journal of thrombosis and haemostasis, 2005-10, Vol.3 (10), p.2211-2218

2005

Volltextzugriff (PDF)

Association between thrombin activatable fibrinolysis inhibitor genotype and levels in plasma: comparison of different assays

British journal of haematology, 2004-03, Vol.124 (5), p.659-665

2004

Volltextzugriff (PDF)

Evidence for an enhanced fibrinolytic capacity in cirrhosis as measured with two different global fibrinolysis tests

Journal of thrombosis and haemostasis, 2012-10, Vol.10 (10), p.2116-2122

2012

Volltextzugriff (PDF)

Increased N‐terminal cleavage of alpha‐2‐antiplasmin in patients with liver cirrhosis

Journal of thrombosis and haemostasis, 2013-11, Vol.11 (11), p.2029-2036

2013

Volltextzugriff (PDF)

Compaction of fibrin clots reveals the antifibrinolytic effect of factor XIII: reply

Journal of thrombosis and haemostasis, 2017-01, Vol.15 (1), p.205-206

2017

Volltextzugriff (PDF)

Basic Principles in Thrombolysis: Regulatory Role of Plasminogen

Thrombosis research, 2001-09, Vol.103, p.S41-S49

2001

Volltextzugriff (PDF)

The role of thrombin activatable fibrinolysis inhibitor in arterial thrombosis at a young age: the ATTAC study

Journal of thrombosis and haemostasis, 2009-06, Vol.7 (6), p.919-927

2009

Volltextzugriff (PDF)

Superficial accumulation of plasminogen during plasma clot lysis

Circulation (New York, N.Y.), 1995-10, Vol.92 (7), p.1883-1890

1995

Volltextzugriff (PDF)

A new functional assay of thrombin activatable fibrinolysis inhibitor

Journal of thrombosis and haemostasis, 2005-06, Vol.3 (6), p.1284-1292

2005

Volltextzugriff (PDF)

Identification and characterization of α1‐antitrypsin in fibrin clots

Journal of thrombosis and haemostasis, 2013-07, Vol.11 (7), p.1319-1328

2013

Volltextzugriff (PDF)

The effect of flow on lysis of plasma clots in a plasma environment

Thrombosis and haemostasis, 2000-03, Vol.83 (3), p.469-474

2000

Volltextzugriff (PDF)

Polylysine as a vehicle for extracellular matrix-targeted local drug delivery, providing high accumulation and long-term retention within the vascular wall

Arteriosclerosis, thrombosis, and vascular biology, 2001-06, Vol.21 (6), p.943-948

2001

Volltextzugriff (PDF)

Binding of carboxypeptidase N to fibrinogen and fibrin

Biochemical and biophysical research communications, 2012-10, Vol.427 (2), p.421-425

2012

Volltextzugriff (PDF)

Thrombin activatable fibrinolysis inhibitor is associated with severity and outcome of severe meningococcal infection in children

Journal of thrombosis and haemostasis, 2008-02, Vol.6 (2), p.268-276

2008

Volltextzugriff (PDF)

Development of a new test for the global fibrinolytic capacity in whole blood

Journal of thrombosis and haemostasis, 2008-01, Vol.6 (1), p.151-157

2008

Volltextzugriff (PDF)

Plasma levels of plasminogen activator inhibitor‐1 and bleeding phenotype in patients with von Willebrand disease

Haemophilia : the official journal of the World Federation of Hemophilia, 2017-05, Vol.23 (3), p.437-443

2017

Volltextzugriff (PDF)

Purification and characterization of the plasminogen activator secreted by human melanoma cells in culture

The Journal of biological chemistry, 1981-07, Vol.256 (13), p.7035-7041

1981

Volltextzugriff (PDF)

Migration of the activation peptide of thrombin‐activatable fibrinolysis inhibitor (TAFI) during SDS–polyacrylamide gel electrophoresis

Journal of thrombosis and haemostasis, 2004-05, Vol.2 (5), p.780-784

2004

Volltextzugriff (PDF)

Thrombin-activatable fibrinolysis inhibitor is associated with severity and outcome of severe meningococcal infection in children

Journal of thrombosis and haemostasis, 2008-02, Vol.6 (2), p.268

2008

Volltextzugriff (PDF)

1 – 25 von 244

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(225)
Mit Volltextzugriff
(182)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(184)
Life Sciences & Biomedicine
(177)
Humans
(168)
Biological And Medical Sciences
(79)
Hematology
(64)
Male
(63)
Female
(61)
Fibrinolysis
(52)
Medical Sciences
(52)
Cardiovascular System & Cardiology
(50)
Peripheral Vascular Disease
(50)
Adult
(43)
Middle Aged
(41)
Aged
(35)
Animals
(33)
Biochemistry & Molecular Biology
(31)
Fundamental And Applied Biological Sciences. Psychology
(31)
Molecular And Cellular Biology
(23)
Oncology
(22)
Surgery
(22)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

New insights into the molecular mechanisms of the fibrinolytic system

The Hypercoagulable State in Cushing's Disease Is Associated with Increased Levels of Procoagulant Factors and Impaired Fibrinolysis, But Is Not Reversible after Short-Term Biochemical Remission Induced by Medical Therapy

An international study on the feasibility of a standardized combined plasma clot turbidity and lysis assay: communication from the SSC of the ISTH

Oxidized high‐density lipoprotein reduces blood clot firmness

The B domain of coagulation factor VIII interacts with the asialoglycoprotein receptor

Compaction of fibrin clots reveals the antifibrinolytic effect of factor XIII

High functional levels of thrombin‐activatable fibrinolysis inhibitor are associated with an increased risk of first ischemic stroke

Association between thrombin activatable fibrinolysis inhibitor genotype and levels in plasma: comparison of different assays

Evidence for an enhanced fibrinolytic capacity in cirrhosis as measured with two different global fibrinolysis tests

Increased N‐terminal cleavage of alpha‐2‐antiplasmin in patients with liver cirrhosis

Compaction of fibrin clots reveals the antifibrinolytic effect of factor XIII: reply

Basic Principles in Thrombolysis: Regulatory Role of Plasminogen

The role of thrombin activatable fibrinolysis inhibitor in arterial thrombosis at a young age: the ATTAC study

Superficial accumulation of plasminogen during plasma clot lysis

A new functional assay of thrombin activatable fibrinolysis inhibitor

Identification and characterization of α1‐antitrypsin in fibrin clots

The effect of flow on lysis of plasma clots in a plasma environment

Polylysine as a vehicle for extracellular matrix-targeted local drug delivery, providing high accumulation and long-term retention within the vascular wall

Binding of carboxypeptidase N to fibrinogen and fibrin

Thrombin activatable fibrinolysis inhibitor is associated with severity and outcome of severe meningococcal infection in children

Development of a new test for the global fibrinolytic capacity in whole blood

Plasma levels of plasminogen activator inhibitor‐1 and bleeding phenotype in patients with von Willebrand disease

Purification and characterization of the plasminogen activator secreted by human melanoma cells in culture

Migration of the activation peptide of thrombin‐activatable fibrinolysis inhibitor (TAFI) during SDS–polyacrylamide gel electrophoresis

Thrombin-activatable fibrinolysis inhibitor is associated with severity and outcome of severe meningococcal infection in children

Suchergebnisse filtern